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Gastric tube after esophagectomy can be the site of local recurrence or the development of second primary tumor
which implies poor prognosis. The study presents an extremely rare case of a patient after Ivor-Lewis
esophagectomy for squamous cell carcinoma, in whom there was detected local recurrence in the anastomosis
associated with metachronous primary tumor in gastric tube. Esophageal reresection with the upper part of the
stomach was performed. Left colonic segment supplied by middle colic vessels transposed through retrosternal
route was used as new esophageal substitute.
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Esophagectomy with lymph node dissections combined
with adjuvant therapy remains the basic method of
esophageal cancer surgical treatment. The stomach is
the most commonly used esophageal substitute after
esophagectomy. Owing to the availability of new, more
precise diagnostic techniques and to the improvement of
the late outcomes of esophageal cancer treatment, there
increases the detectability of the cases of second primary
malignancies in the stomach [1]. The coexistence of
squamous cell carcinoma with malignant and benign
cancers of other organs (such as the head, neck, upper
respiratory tract, and of the remaining part of the gastro-
intestinal tract) is known and concerns nearly 10% to
21% of patients [1,2]. This phenomenon even has mean-
ingful term: ‘field cancerization’ [3]. The coexistence of
primary gastric and esophageal cancer has been esti-
mated to reach 3% to 7% [4,5]. The incidence of primary
cancer within the gastric graft after esophagectomy has
been estimated to be related to <2.1% of patients [4-6].
The surgical treatment of a cancer diagnosed in the
gastric tube after esophagectomy is a difficult and rarely
undertaken surgical challenge associated with the risk
for severe complications and high mortality.* Correspondence: jablonski_s@vp.pl
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A female patient, MZ, aged 61 years, referred primarily
for surgical treatment due to esophageal cancer detected
in the epicardial region. Endoscopic examination
revealed a primary tumor located 30 cm from the inci-
sors. Endoscopic evaluation of the stomach lumen was
impossible due to esophageal stricture at the tumor
level. Histopathological examination of tumor specimens
led to the diagnosis of squamous cell carcinoma. Pre-
operative thoracic computed tomography (CT) detected
neither tumor infiltration on the surrounding tissues nor
the enlargement of the regional lymph nodes in the
thorax and abdominal cavity.
Based on the results of diagnostic investigations which
confirmed the possibility of local excision of the tumor,
the patient was qualified for surgical treatment.Primary operation
Partial Ivor-Lewis esophago-gastrectomy was performed
with conventional two-field en block lymphadenectomy
using a gastric tube as an esophageal substitute. The
esophagogastroplasty was performed in the right pleural
cavity. The postoperative histopathological examination
showed squamous cell carcinoma keratodes G-2 invad-
ing the adventitia without lymph node metastasis
(pT3N0M0, Stage II A). Microscopically esophageal and
gastric rings were free from neoplastic cells. Thel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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nodes of the following groups were removed: upper
thoracic paraesophageal lymph nodes (2), right thoracic
paratracheal lymph nodes (1), bifurcation lymph nodes
(2), middle thoracic paraesophageal lymph nodes (2),
right pulmonary hilar lymph nodes (1), lower thoracic
paraesophageal lymph nodes (2), diaphragmatic lymph
nodes (1), posterior mediastinal lymph nodes (2), lesser
curvature lymph nodes (3), left gastric artery lymph
nodes (1), and common hepatic artery lymph nodes (1).
All lymph nodes were free of cancer cells. The patient’s
postoperative course was uncomplicated and she was
discharged from hospital after 17 days. After surgery, the
patient did not report for further treatment at an onco-
logical center.
The follow-up endoscopy performed 6 months after
esophagectomy showed: (A) mucosa at the site of anas-
tomosis: uneven, congested with superficial lesions cov-
ered with fibrin, unchanged esophageal mucous
membrane proximal to anastomosis. About 3 cm below
the anastomosis was a stocky polyp of 10 to 12 mm in
diameter (B) surrounded by normal gastric mucosa.
Congested mucosa without lesions were in the gastric
tube distal segment. The results of histopathological
examinations revealed: (A) gastric mucosa segment with
the features of foveolar hyperplasia, (B) polyp from the
gastric tube - squamous cell carcinoma keratodes (suspi-
cion of local recurrence). The result of CT after esopha-
gectomy was (Figure 1): anastomosis between the
stomach and the esophagus constructed above tracheal
bifurcation. No recurrence of radiological traits of the
growth process were found at the anastomosis site.
There was visible segmental gastric wall thickeningFigure 1 Computed tomography (scan A, B): gastroesophageal anasto
thickening of gastric mucosa.(7 mm) about 3 to 4 cm below the anastomosis without
infiltration to the surrounding structures. There were
enlarged single paratracheal and subcalcarine lymph
nodes. No focal lesions were observed in the lungs.
The patient was qualified for reoperation with the pos-
sibility using a colon as esophageal substitute. Earlier
performed diagnostic endoscopy revealed no patho-
logical lesions nor vascular anomalies in angio CT of ab-
dominal vasculature.
Surgical technique
Operation was started with right rethoracotomy to re-
lease carefully the gastric tube from adhesions with the
right lung and thoracic wall. The esophageal wall thick-
ened circumferentially about 1 to 2 cm above the anas-
tomosis, characteristic of recurrence, was detected by
intraoperative palpation (not shown on endoscopy and
CT). En bloc dissection of residual esophagus was per-
formed to the level of the apex of the chest and then the
esophageal stump was cut 8 cm above the anastomosis
(Figure 2). After separation of anastomoses between the
gastric tube and the lung numerous air leaks from its
surface were observed. Single lymph nodes were
removed in the site after conduit. Gastric tube was
returned back to the peritoneal cavity together with the
distal part of esophageal stump. The resection of two-
thirds of the proximal part of the stomach with the
esophageal stump was performed through laparotomy.A
new conduit was prepared from left colonic segment
supplied by the middle colic artery (Figure 3). The
esophageal stump was dissected from a left neck incision
and limited lymphadenectomy was performed (paraeso-
phageal and deep cervical lymph nodes). The right colonmosis at the level of tracheal bifurcation, below visible
Figure 2 The range of gastric tube and esophageal stump
resection.
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sion through the retrosternal route. Hand-sewn anasto-
mosis was made in the neck between the esophageal
stump and antiperistaltic colonic loop. The distal end ofconduit was anastomosed to the posterior gastric wall.
Initially, jejunostomy feeding was introduced and after
5 days it was replaced with oral feeding. The total period
of hospitalization was 15 days.
The results of postoperative histopathological examin-
ation were (a) distal esophageal stump with anastomosis:
recurrence of squamous cell carcinoma keratodes G-2,
tumor emboli in lymphatic vessels, proximal esophageal
stump free of tumor infiltration; (b) tumor located in
gastric tube, squamous cell carcinoma pT2N0Mx (pri-
mary focus), the tumor sounded by normal gastric mu-
cosa; and (c) lymph nodes from the thoracic area (7) and
neck (4) without tumor cells.
Postoperative course
Eight weeks after surgery, in the course of the second
cycle of chemotherapy, dysphagia developed. Endoscopy
revealed no anastomotic stenosis. Within a 3-week
period an effective endoscopy-guided dilatation with a
balloon was performed twice. Six months after reopera-
tion no recurrence of the neoplastic process was
observed in follow-up diagnostic tests.
Discussion
The use of the stomach as an esophageal substitute after
esophagectomy is commonly accepted by the majority of
surgeons [4,5]. The stomach is by choice the first organ
owing to such characteristics as: availability and length,
plasticity, and rich submucosal vascular network [6,7].
However, part of patients can manifest the second pri-
mary tumor. The second primary carcinoma was defined
according to the criteria described by Warrren and
Gates [8]: (1) the tumours had to be evidently malignant
on histological examination; (2) they had to be separated
by normal mucosa; and (3) the possibility of a second
tumor representing a metastasis had to be excluded. In
the case described by us, besides the local recurrence in
the anastomosis we dealt with the second primary tumor
in the gastric tube which fulfilled histopathological cri-
teria of metachronous tumour. Esophageal stenosis often
makes endoscopic evaluation of the stomach impossible.
In the observation of Koide [4] as much as 89.3% of gas-
tric tumors coexisting with esophageal carcinoma were
located at the upper or middle third of the stomach and
nearly one-third of them were not detected before surgi-
cal treatment. We cannot exclude that due to esophageal
stenosis, the secondary gastric tumor was not detected
in our patient in the first endoscopy. Gastric metachro-
nous carcinomas which are diagnosed on the basis of
clinical symptoms have poor prognosis, whereas those
detected early in the course of endoscopic screening
have much better prognosis, particularly if they are
related only to the mucosa [9,10]. Synchronous primary
gastric cancers in patients with esophageal carcinoma
Figure 3 Vascularization of the long segment of transverse colon and left part of the colon on the middle colic artery.
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the same way as primary cancer [4,10]. If they are lim-
ited to mucosa, they can be resected during pre- or
intraoperative endoscopy [11,12]. Other locally operative
tumors can be resected during esophagectomy by per-
forming mucosal resection using gastrotomy or ad-
equately extending the range of gastric resection.
In the case of metachronous tumors located in the
gastric tube the therapeutic management depends on
the depth of tumor infiltration to the gastric wall [10-
12]. In the case of second locally inoperable tumors and
local recurrence the therapy is limited to chemotherapy,
radiation therapy, or a combination of these modalities
[13]. After esophagectomy, endoscopic mucosal resec-
tion is the therapy of choice for early gastric cancer
[6,10,12]. In the selected cases of metachronous tumors
limited to gastric substitute wall reconstructed retroster-
nally, the tumor can be resected using minimally inva-
sive videothoracoscopic technique [14]. The surgical
treatment of advanced secondary cancers in the gastric
tube is a difficult and rarely undertaken challenge due toTable 1 Table summarizing published cases of metachronous
Authors (published year) Cases (n) Surgical treatment Recurrence of t
Suzuki et al. [11] 10 4 (NR)
Sugiura et al. [12] 26 10 3 cases of GC, 2
Matsubara et al. [1] 17 NR NR
Okamoto et al. [10] 8 5 2
Motoyama et al. [5] 2 2 No
Yoon et al. (2010) [6] 10 6 1 case of EC
Oki et al. [15] 10 5 2 cases (NR)
EC, oesophageal cancer; GC, gastric cancer; ; m, months; NR, not reported; RLN, regcomplicated local conditions, the risk of severe compli-
cations, and high mortality. Table 1 demonstrates the lit-
erature data summing up the results of the treatment of
metachronous neoplastic lesions in the gastric conduit.
Akiyama and Nakayama reported that in surgeries due
to a cancer in the gastric tube the mortality rate could
reach 50% of cases (14 of 28) [7]. In low grade tumors
located in the upper third of the stomach it is suggested
to perform proximal gastrectomy with the dissection of
regional lymph nodes. In high grade but operative sec-
ond cancers of the stomach total gastrectomy combined
with esophagectomy is recommended [6,10,15]. The sur-
gery allows removal of both tumors and complete dis-
section of the regional lymph nodes. According to Oki
et al. the prognosis of patients who underwent resection
was better than that of the other patients [15].
Gastric tube resection requires reconstruction of
gastrointestinal tract with the useof colonic or small in-
testine conduit. In such situations colon graft is pre-
ferred owing to its proper length, reliable blood supply,
and fewer complications [11,12,15]. In the case describedneoplastic lesions in the gastric conduit
umor Follow-up period Survival rate
(7, 42, 60, 99 m) 3 alive (NR)
cases of EC, 4 cases of RLN (NR) 1 alive (5 months)
5 years 45%
2 and 81 m 3 alive (NR)
4 and 55 m (NR)
median 14 m (range 1-97) 70% (5 years)
2-8 years 3 alive (NR)
ional lymph node metastases.
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transposition for four reasons: the need for more exten-
sive resection of the esophagus; the risk of locoregional
recurrence; planned radiotherapy of the area of posterior
mediastinum; and intensive air leak from the lung surface.
Similar management was recommended by Yoon et al.
[6]. The non-complicated postoperative course confirmed
the rightness of this choice. We think that more frequent
use of a colon graft as the first choice esophageal substi-
tute is worth considering owing to lower risk of the devel-
opment of second primary tumor or local recurrence at
the site of esophagus removal.Conclusion
Gastric tube resection with the creation of a new
esophageal substitute from the colon is a difficult but
possible treatment option in selected cases of recurrence
or second primary cancer of the stomach detected in
postoperative follow-up.
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